Cellosaurus K562 Dox (CVCL_E6HY)
| Cell line name | K562 Dox | ||||||
|---|---|---|---|---|---|---|---|
| Synonyms | K562-Dox; K562/DOX; K562/Dox | ||||||
| Accession | CVCL_E6HY | ||||||
| Resource Identification Initiative | To cite this cell line use: K562 Dox (RRID:CVCL_E6HY) | ||||||
| Comments | From: Ashman, Leonie K.; University of Newcastle; Adelaide; Australia. Population: Caucasian. Characteristics: Stably overexpresses ABCB1 (PubMed=21718141). Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. | ||||||
| Sequence variations |
| ||||||
| Disease | Blast phase chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C9110) Chronic myeloid leukemia (ORDO: Orphanet_521) | ||||||
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||||||
| Hierarchy | Parent: CVCL_0004 (K-562) Children:
| ||||||
| Sex of cell | Female | ||||||
| Age at sampling | 53Y | ||||||
| Category | Cancer cell line | ||||||
| Publications | PubMed=21718141; DOI=10.3109/10428194.2011.591013 PubMed=27536777; DOI=10.1371/journal.pone.0161470; PMCID=PMC4990177 | ||||||
| Entry history | |||||||
| Entry creation | 10-Apr-2025 | ||||||
| Last entry update | 10-Apr-2025 | ||||||
| Version number | 1 | ||||||